# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001159036-23-000011
Filing Date
2023-02-21
Accepted
2023-02-21 16:21:37
Documents
14
Period of Report
2023-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | halo-20230221.htm iXBRL | 8-K | 41881
2 | EX-99.1 | ex991q420228-k.htm | EX-99.1 | 226776
6 | GRAPHIC | halozymea23.jpg | GRAPHIC | 701236
| Complete submission text file | 0001159036-23-000011.txt |  | 1368399

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20230221.xsd | EX-101.SCH | 1915
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20230221_lab.xml | EX-101.LAB | 24137
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20230221_pre.xml | EX-101.PRE | 12520
8 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20230221_htm.xml | XML | 10820

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 23648508
SIC: 2836 Biological Products, (No Diagnostic Substances)